Ionis Pharmaceuticals | IONS - Interest Income


Ionis Pharmaceuticals reported $-0.66 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
Alnylam Pharmaceuticals USD 28.68M 1.19M Sep/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Astellas Pharma JPY 4.12B 2.94B Mar/2024
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Celltrion KRW 676.66M 6.85B Jun/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 15.92M 867K Sep/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 1.81M 2.5M Jun/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Moderna USD 73M 8M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
OPKO Health USD 3.02M 264K Sep/2025
Pfizer USD 0.62 156M Sep/2025
Pharma Mar EUR 4.8M 6.4M Dec/2024
Qiagen NV USD 15.07M 1.21M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Sartorius EUR 54.9M 77.1M Mar/2025
Tilray USD 12.83M 20.19M May/2024
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 6.65M 4.01M Jun/2025